Pediatric Radiology

, Volume 42, Issue 7, pp 859–866 | Cite as

Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI—typical, atypical, pre- and post-treatment evaluation

  • Arthur B. Meyers
  • Alexander J. Towbin
  • James I. Geller
  • Daniel J. Podberesky
Pictorial Essay

Abstract

Gadoxetate disodium (Gd-EOB-DTPA) is a hepatobiliary MRI contrast agent widely used in adults for characterization of liver tumors and increasingly used in children. Hepatoblastoma is the most common primary hepatic malignancy of childhood. In this review, we describe our experience with this agent both before and after initiating therapy in children with hepatoblastoma.

Keywords

Hepatoblastoma Gadoxetate disodium Gd-EOB-DTPA Children 

References

  1. 1.
    Ringe KI, Husarik DB, Sirlin CB et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR 195:13–28PubMedCrossRefGoogle Scholar
  2. 2.
    Cruite I, Schroeder M, Merkle EM et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR 195:29–41PubMedCrossRefGoogle Scholar
  3. 3.
    Meyers AM, Towbin AJ, Serai A et al (2011) Characterization of pediatric liver lesions with gadoxetate disodium. Pediatr Radiol 41:1183–1197PubMedCrossRefGoogle Scholar
  4. 4.
    Zech CJ, Herrmann KA, Reiser MF et al (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52PubMedCrossRefGoogle Scholar
  5. 5.
    Choi JY, Kim MJ, Park YM et al (2011) Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. AJR 197:399–405PubMedCrossRefGoogle Scholar
  6. 6.
    Goodwin MD, Dobson JE, Sirlin CB et al (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31:1547–1568CrossRefGoogle Scholar
  7. 7.
    Vasanawala S (2010) MRI of the liver—how to do it. Pediatr Radiol 40:431–437PubMedCrossRefGoogle Scholar
  8. 8.
    Marrone G, Maggiore G, Carollo V et al (2011) Biliary cystadenoma with bile duct communication depicted on liver-specific contrast agent-enhanced MRI in a child. Pediatr Radiol 41:121–124PubMedCrossRefGoogle Scholar
  9. 9.
    Tamrazi A, Vasanawala SS (2011) Functional hepatobiliary MR imaging in children. Pediatr Radiol 22:1250–1258CrossRefGoogle Scholar
  10. 10.
    Das CJ, Dhingra S, Gupta AK et al (2009) Imaging of paediatric liver tumours with pathological correlation. Clin Radiol 64:1015–1025PubMedCrossRefGoogle Scholar
  11. 11.
    Imbach P (2006) Hepatic tumors. In: Imbach P, Kuhne T, Arceci RJ (eds) Pediatric oncology: a comprehensive guide. Springer, New York, pp 187–191CrossRefGoogle Scholar
  12. 12.
    Chung EM, Lattin GE, Cube R et al (2011) Pediatric liver masses: radiologic-pathologic correlation part 2. Malignant tumors. Radiographics 31:483–507PubMedCrossRefGoogle Scholar
  13. 13.
    Roebuck DJ, Aronson D, Clapuyt P et al (2005) PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37:123–132CrossRefGoogle Scholar
  14. 14.
    Vogel TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67Google Scholar
  15. 15.
    Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMedGoogle Scholar
  16. 16.
    Towbin AJ, Luo GG, Yin H et al (2010) Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 41:341–349PubMedCrossRefGoogle Scholar
  17. 17.
    Asbach P, Klessen C, Koch M et al (2007) Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver. Clin Imaging 31:244–252PubMedCrossRefGoogle Scholar
  18. 18.
    Christison-Lagay ER, Burrows PE, Alomari A et al (2007) Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62–67PubMedCrossRefGoogle Scholar
  19. 19.
    Goshima S, Kanematsu M, Watanabe H et al (2010) Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR 195:941–946PubMedCrossRefGoogle Scholar
  20. 20.
    Prokurat A, Kluge P, Kosciesza A et al (2002) Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 39:510–518PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Arthur B. Meyers
    • 1
    • 3
    • 4
  • Alexander J. Towbin
    • 1
  • James I. Geller
    • 2
  • Daniel J. Podberesky
    • 1
  1. 1.Department of RadiologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of Hematology/OncologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  3. 3.Department of RadiologyMedical College of WisconsinMilwaukeeUSA
  4. 4.Department of Pediatric ImagingChildren’s Hospital of WisconsinMilwaukeeUSA

Personalised recommendations